
|
Baden-Württemberg International in cooperation
with the Government of Ontario, Canada and Invest Ontario invite you to an
exclusive networking lunch.
When: November 24, at 12 p.m.
Where: Ontario Investment and Trade Centre
This event brings together Ontarios health tech innovators for insights on Baden-Württemberg,
the state in the German South-West.
We would like to provide more information on the industry and research landscape of Baden-Württemberg, what makes it a perfect place for business expansion, and most importantly, how you can become part of this innovative research and business ecosystem.
And because our name “Baden-Württemberg” is hard to remember, just call us: The LÄND.
What awaits you?
Whether you're exploring international growth for the first time or actively scouting your next location, this is a unique opportunity to speak directly with the people who can help make it happen.
We look forward to welcoming you as our guest.
Register now!
Registration is open until November 24th
Please note that the number of participants is limited.
Confirmations will be issued on a first-come, first-served basis and suitability in terms of subject matter.
P.s. Please note that this event is organized by Baden-Württemberg International (BW_i), the state’s agency for international business development. EXPÄND INTO THE LÄND is part of our initiative, which supports companies in exploring new markets, partnerships, and business opportunities in Baden-Württemberg.
|
| 12:00 p.m. |
Registration
|
| 12:15 - 12:35 p.m. |
Opening Remarks and Welcome:
|
|
|
|
|
| 12:35 - 12:55 p.m. |
Welcome to The LÄND! Expand your life science business to Europe’s innovation hot spot.
|
| 1:00 - 1:55 p.m. |
Networking, Q&A over Finger Food Lunch
|
| 1:55 - 2:00 p.m. |
Closing Remarks
|
| 2:00- 3:00 p.m. |
Speed Dating Slots (10 min. slots)
|
|
About The State of Baden-Württemberg:
Baden-Württemberg is a state in southwestern Germany, bordering France, Switzerland, and Its capital is Stuttgart, home to major automotive companies such as Mercedes-Benz and Porsche. The state is known for its strong economy, driven by mechanical engineering, automotive manufacturing, and medical technology.
Further, it is home to a dense network of innovative small and medium-sized enterprises, often referred to as the "Mittelstand” and to many engineers, with Baden-Württemberg being the German state with the highest engineering density.
Beyond industry, Baden-Württemberg boasts diverse landscapes, from the Black Forest and Lake Constance to the vineyards of the Rhine Valley. The region has a rich cultural heritage, with historic cities like Heidelberg, Freiburg, and Tübingen known for their renown universities and picturesque old towns. With around 11 million residents, it's one of Germany's most prosperous and densely populated states, combining traditional charm with cutting-edge technology and research.
|
|
|
|
|
|
|
| |
The LÄND - the Med Tech Hub of Germany:
Baden-Württemberg is Germany's number one medtech location, home to 843 medical technology companies employing 53,600 people and generating EUR 14.84 bn / USD 17.28bn in revenue. Its main modalities include surgical instruments and endoscopy, implants and exoprostheses, therapeutic systems and devices, imaging and diagnostic equipment, and increasingly digital health, telemedicine, and robotics-driven solutions. The region's core strength lies in the Tuttlingen/Neckar-Alb cluster, often called the "The Medical Mountains", one of Europe's most significant medtech hubs and home to global players alongside a dense network of specialized, family-owned "hidden champion" manufacturers, complemented by growing centers in Stuttgart/Tübingen and Rhein-Neckar (Mannheim/Heidelberg).
|
| |
The LÄND’s diverse therapeutic landscape:
Baden-Württemberg's therapeutics landscape centers on mRNA and small-molecule therapeutics, biologics, and cell and gene therapies driving regenerative and personalized medicine, with Tübingen-Reutlingen (BioRegio STERN) and the joint Tübingen-Ulm oncology center NCT SüdWest as key hubs. Antibody therapies and TCR-based immuno-oncology are led by the Heidelberg-Mannheim region (BioRN cluster) through DKFZ, the German Cancer Research Center. Biologics manufacturing is concentrated around Biberach and Ulm (BioPharma Cluster South Germany), anchored by Boehringer Ingelheim and Fraunhofer IGB's Virus-based Therapies branch. Biosimilars, generics, DNA/RNA platforms, plant-based and anthroposophic therapeutics, and prophylactic and veterinary vaccines round out the sector.
|
| |
The LÄND – Pioneers in (Health) Technology:
Baden-Württemberg's life science sector positions itself as a leading hub for emerging health technologies, anchored by Cyber Valley in the Stuttgart-Tübingen region, one of Europe's leading AI research initiatives, combining excellent fundamental research with practical application in machine learning, computer vision, and intelligent robotics. It is further growing its application cases in medical diagnostics and personalized medicine. AI-driven imaging and digital biomarkers are increasingly used in precision oncology, exemplified by the work of the German Cancer Research Center (DKFZ) in Heidelberg's on digital biomarkers for melanoma, breast, and prostate cancer, alongside broader imaging efforts in the Rhine-Neckar Area / Heidelberg. A further emerging field is bio-intelligence, an interdisciplinary approach integrating biological and technical system, spanning AI-supported drug formulation to bio-hybrid systems such as active prostheses and exoskeletons. Additional focus areas include quantum technology applications in health and continued state funding for translating AI research into clinical care and nursing.
|
| |
More general information:
In Germany, the healthcare system is built on the principle of social insurance and is one of the oldest and most comprehensive in the world. Its core is the statutory health insurance system which covers around 90% of the population through mandatory or voluntary membership. It is financed through income-based contributions, split equally between employers and employees.
Germany's statutory health insurance system offers significant opportunities for foreign MedTech companies willing to navigate its structure. Because the GKV covers almost the whole German population under a unified benefits framework, a single successful reimbursement decision opens access to nearly the entire German market at once, rather than requiring negotiations with a fragmented patchwork of private payers as in the US.
The DiGA fast-track pathway for digital health applications is particularly attractive to foreign Health-IT companies, allowing provisional reimbursement within weeks of listing at the Federal Institute for Drugs and Medical Devices while clinical evidence is generated in parallel, which is a much faster route to market than in most other European countries.
|
|
|
Baden-Württemberg and Ontario share one of Baden-Württemberg's oldest and most vibrant international partnerships, dating back to a landmark agreement signed on February 18, 1987. Nearly four decades of friendship that continues to thrive today. This bond was freshly renewed through a Memorandum of Understanding signed in Stuttgart, Baden-Württemberg in October 2022, injecting new energy into cooperation on innovation and science, and complemented by a dedicated Faculty Mobility Programme that keeps researchers moving enthusiastically between the two regions' universities. On the economic front, the automotive and mobility sectors truly drive the partnership forward, anchored by a dynamic joint MoU between Ontario's OVIN (Ontario Vehicle Innovation Network) and Baden-Württemberg's e-mobil BW agency, cementing both regions' standing as powerhouses of the global automotive industry. Underscoring just how much this relationship has grown, Baden-Württemberg opened a dedicated economic representation office in Toronto in 2023, opening exciting new doors for companies on both sides in future-oriented fields like hydrogen, clean tech, aerospace, AI, and especially the health tech industry.
|
|
|
|
Your Contact at the event:
|
|
Your Contact for the registration process:
|
|
![]() |
![]() |
|||
| Ms. Michèle Benker | Ms. Anna Tzamvasidou | |||
|
|
Manager Corporate & Investor Services
Biotech, Pharma, and Chemicals Phone: +49 (0) 711 227 87-69 E-Mail: michele.benker@bw-i.de |
|
Manager Corporate & Investor Services
Request & Investor Support
Phone: +49 (0) 711 227 87-64
E-Mail: anna.tzamvasidou@bw-i.de |